Trials / Completed
CompletedNCT01743625
Safety and Efficacy Study of COV155 for Post-operative Bunionectomy Pain
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Evaluation of the Safety and Analgesic Efficacy of COV155 Tablets in Moderate to Severe Post-Operative Bunionectomy Pain Followed by an Open-Label Extension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 406 (actual)
- Sponsor
- Mallinckrodt · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to show the effectiveness of COV155 compared to placebo in subjects with acute moderate to severe pain following bunionectomy surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | COV155 | COV155 tablets |
| DRUG | placebo |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-05-01
- Completion
- 2013-07-01
- First posted
- 2012-12-06
- Last updated
- 2016-10-19
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01743625. Inclusion in this directory is not an endorsement.